Document Detail


Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic.
MedLine Citation:
PMID:  19676066     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVES: To quantify endometrial and subendometrial blood flow in Caucasian women with polycystic ovarian syndrome (PCOS) and to determine whether these values differ according to the phenotypic expression of PCOS. METHODS: Transvaginal pelvic ultrasound was performed on the 3(rd)-5(th) day of the menstrual cycle in 36 women with PCOS and 36 controls to examine the endometrial and subendometrial vascularity. The subendometrial and endometrial blood flow indices (vascularizaton index (VI), flow index (FI) and vascularization flow index (VFI)) were measured using three-dimensional power Doppler angiography. Uterine artery blood flow was assessed through analysis of two-dimensional (2D) pulsed-wave Doppler waveforms. Analysis was performed to compare PCOS with non-PCOS women, and subgroup analysis was performed of the PCOS women categorized according to their phenotypic manifestation. RESULTS: There were no significant differences in endometrial volume, subendometrial vascularity and uterine artery blood flow between women with PCOS and controls after controlling for body mass index (BMI). On subgroup analysis, compared with anovulatory but clinically normoandrogenic women with polycystic ovaries (PCO) and with controls, women with PCO who were both clinically hyperandrogenic and anovulatory had significantly lower endometrial (VI: 0.57% vs. 1.11% and 0.86%, respectively, both P = 0.01; VFI: 0.14 vs. 0.42 and 0.28, respectively, both P = 0.02) and subendometrial (VI: 1.59% vs. 3.17% and 2.47%, P = 0.01 and 0.02, respectively; VFI: 0.50 vs. 1.67 and 0.96, P = 0.01 and 0.02, respectively) blood flow. Moreover, clinically hyperandrogenic but ovulatory women with PCO also had significantly lower endometrial blood flow (VI: 0.52% vs. 1.11%, P = 0.04) than did anovulatory but clinically normoandrogenic women with PCO. There were no differences in any of the 2D pulsed-wave Doppler measures of blood flow between the subgroups. CONCLUSIONS: Subendometrial and endometrial blood flow is significantly impaired in women with PCOS who have clinical signs of hyperandrogenism.
Authors:
P Lam; I Johnson; N Raine-Fenning
Related Documents :
952306 - Actions of the uterine relaxant, fenoterol, on uteroplacental hemodynamics in human sub...
10659896 - Uterine and fetal doppler flow changes after misoprostol and oxytocin therapy for induc...
7163976 - Blood flow during pregnancy in the rat: i. flow patterns to maternal organs.
16677926 - Flow index evaluation of 3-d volume flow images: an in vivo and in vitro study.
18775556 - Organohalogen concentrations in blood and adipose tissue of southern beaufort sea polar...
6637856 - Morphometric analysis of the corpus luteum of 16-day pregnant rats: the effect of prepa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology     Volume:  34     ISSN:  1469-0705     ISO Abbreviation:  Ultrasound Obstet Gynecol     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-08-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9108340     Medline TA:  Ultrasound Obstet Gynecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  326-34     Citation Subset:  IM    
Affiliation:
Department of Obstetrics & Gynaecology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. lampomui@cuhk.edu.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defe...
Next Document:  TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.